HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GS12021

inhibits inflammation and macrophage chemotaxis; structure in first source

Also Known As:

3',5-diallyl-4'-methoxy-(1,1'-biphenyl)-2-yl morpholine-4-carboxylate

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Biphenyl Compounds: 7
        GS12021: 1
        Benzyl Compounds: 2
        Lignans: 1113
        GS12021: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Oxazines: 9
    - Morpholines: 6
      - GS12021: 1

Experts

1.	Bae, Eun Ju: 1 article (01/2015)
2.	Fei, Xiang: 1 article (01/2015)
3.	Jung, Jae-Kyung: 1 article (01/2015)
4.	Ka, Sun-O: 1 article (01/2015)
5.	Kim, Sora: 1 article (01/2015)
6.	Lee, Youngyi: 1 article (01/2015)
7.	Park, Byung-Hyun: 1 article (01/2015)
8.	Seo, Seung-Yong: 1 article (01/2015)

Related Diseases

1.

Inflammation (Inflammations)

01/01/2015 - "Here, we found that a new 4-O-methylhonokiol analog, 3',5-diallyl-4'-methoxy-[1,1'-biphenyl]-2-yl morpholine-4-carboxylate (GS12021) inhibited LPS- or TNFα-stimulated inflammation in macrophages and adipocytes, respectively. "
01/01/2015 - "The new 4-O-methylhonokiol analog GS12021 inhibits inflammation and macrophage chemotaxis: role of AMP-activated protein kinase α activation."

Related Drugs and Biologics

1.	AMP-Activated Protein Kinases
2.	4-O-methylhonokiol
3.	diphenyl (biphenyl)